The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Cipriano, Mariateresa ^a   Gouveia Figueira, Sandra ^a   Persson, Emma ^a   Nording, Malin ^a   Fowler, Christopher J ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cannabinoid receptor; Epidermal growth factor; Monoacylglycerol lipase; Prostate cancer

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; 2-ARACHIDONYLGLYCEROL; 3-(2-HYDROXY-4-(1,1-DIMETHYLHEPTYL)PHENYL)-4-(3-HYDROXYPROPYL)CYCLOHEXANOL; 4 [BIS(1,3 BENZODIOXOL 5 YL)HYDROXYMETHYL] 1 PIPERIDINECARBOXYLIC ACID 4 NITROPHENYL ESTER; ACYLGLYCEROL; ACYLGLYCEROL LIPASE; AMIDE; ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID; CANNABINOID 1 RECEPTOR; CYCLOHEXANOL DERIVATIVE; ENDOCANNABINOID; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ETHANOLAMINE DERIVATIVE; N-ACYLETHANOLAMINES; PIPERIDINE DERIVATIVE;

AGONISTS; ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ARACHIDONIC ACIDS; BENZODIOXOLES; CANNABINOIDS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOHEXANOLS; ENDOCANNABINOIDS; ENZYME INHIBITORS; ETHANOLAMINES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCERIDES; HUMANS; MALE; MONOACYLGLYCEROL LIPASES; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PROSTATE; RECEPTOR, CANNABINOID, CB1; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84903854997     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-441     Document Type: Article

References (20)

1. The endocannabinoid system and cancer: therapeutic implication. Guindon J, Hohmann AG, Br J Pharmacol 2011 163 1447 1463 10.1111/j.1476-5381.2011.01327. x 21410463
2. 2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Nithipatikom K, Endsley MP, Isbell MA, Falck JR, Iwamoto Y, Hillard CJ, Campbell WB, Cancer Res 2004 64 8826 8830 10.1158/0008-5472.CAN-04-3136 15604240 (Pubitemid 39665485)
3. Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. Nomura DK, Lombardi DP, Chang JW, Niessen S, Ward AM, Long JZ, Hoover HH, Cravatt BF, Chem Biol 2011 18 846 856 10.1016/j.chembiol.2011.05.009 21802006
4. Expression and function of fatty acid amide hydrolase in prostate cancer. Endsley M, Thill R, Choudhry I, Williams C, Kajdacsy-Balla A, Campbell W, Nithipatikom K, Int J Cancer 2008 123 1318 1326 10.1002/ijc.23674 18566995
5. 1 receptor expression and regulation by IL-4. Thors L, Bergh A, Persson E, Hammarsten P, Stattin P, Egevad L, Granfors T, Fowler CJ, PLoS One 2010 5 12275 10.1371/journal.pone.0012275 20808855
6. Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. Mimeault M, Pommery N, Wattez N, Bailly C, Hénichart J-P, Prostate 2003 56 1 12 10.1002/pros.10190 12746841 (Pubitemid 36613150)
7. Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients. Hammarsten P, Karalija A, Josefsson A, Rudolfsson SH, Wikström P, Egevad L, Granfors T, Stattin P, Bergh A, Clin Cancer Res 2010 16 1245 1255 10.1158/1078-0432.CCR-09-0103 20145160
8. 1 receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer. Fowler CJ, Hammarsten P, Bergh A, PLoS One 2010 5 15205 10.1371/journal.pone.0015205 21203460
9. Targeting the endocannabinoid system for the treatment of cancer-a practical view. Fowler CJ, Gustafsson SB, Chung SC, Persson E, Jacobsson SOP, Bergh A, Curr Top Med Chem 2010 10 814 827 10.2174/156802610791164201 20370711
10. The cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α protein. Fiori JL, Sanghvi M, O'Connell MP, Krzysik-Walker SM, Moaddel R, Bernier M, Br J Pharmacol 2011 164 1026 1040 10.1111/j.1476-5381. 2011.01384.x 21449913
11. The Valley of Death in anticancer drug development: a reassessment. Adams DJ, Trends Pharmacol Sci 2012 33 173 180 10.1016/j.tips.2012.02.001 22410081
12. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK, Nature 2009 459 428 432 10.1038/nature08012 19363473
13. Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid. Fowler CJ, Jonsson K-O, Andersson A, Juntunen J, Järvinen T, Vandevoorde S, Lambert DM, Jerman JC, Smart D, Biochem Pharmacol 2003 66 757 767 10.1016/S0006-2952(03)00392-7 12948856 (Pubitemid 37011414)
14. Endocannabinoid content in fetal bovine sera-Unexpected effects on mononuclear cells and osteoclastogenesis. Marazzi J, Kleyer J, Paredes JMV, Gertsch J, J Immunol Methods 2011 373 219 228 10.1016/j.jim.2011.08.021 21920367
15. Suppression of nerve growth factor trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, Di Marzo V, Endocrinology 2000 141 118 126 10614630 (Pubitemid 32260350)
16. Potential upstream regulators of cannabinoid receptor 1 signalling in prostate cancer: a Bayesian network analysis of data from a tissue microarray. Häggström J, Cipriano M, Plym Forshell L, Persson E, Hammarsten P, Stella N, Fowler CJ, Prostate 2014 74 1107 1117 10.1002/pros.22827 24913716
17. D9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. Ruiz L, Miguel A, Díaz-Laviada I, FEBS Letts 1999 458 400 404 10.1016/S0014-5793(99)01073-X (Pubitemid 29433843)
18. 2 receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction. Sánchez M, Ruiz-Llorente L, Sánchez A, Díaz-Laviada I, Cell Signal 2003 15 851 859 10.1016/S0898-6568(03)00036-6 12834810 (Pubitemid 36776659)
19. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways. Bradshaw HB, Rimmerman N, Hu SS-J, Benton VM, Stuart JM, Masuda K, Cravatt BF, O'Dell DK, Walker JM, BMC Biochem 2009 10 14 10.1186/1471-2091-10-14 19460156
20. Development and validation of a sensitive UPLC-ESI-MS/MS method for the simultaneous quantification of 15 endocannabinoids and related compounds in milk and other biofluids. Gouveia-Figueira S, Nording ML, Anal Chem 2014 86 1186 1195 10.1021/ac403352e 24377270